157 GENES FOUND

Show / hide columns »

XML | RDF | TAB | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
ACHEAcetylcholinesterase (Yt blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Tissue enhanced
ALPPL2Alkaline phosphatase, placental-like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Cytosol
Tissue enhanced
BCHEButyrylcholinesteraseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
BGLAPBone gamma-carboxyglutamate (gla) proteinFDA approved drug targets
Predicted secreted proteins
Mixed
BLVRBBiliverdin reductase BEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Cytosol
Expressed in all
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
C4AComplement component 4A (Rodgers blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C4BComplement component 4B (Chido blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C5Complement component 5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched
CCL2Chemokine (C-C motif) ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Expressed in all
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD4CD4 moleculeCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane
Expressed in all
CD80CD80 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD86CD86 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumGroup enriched
CHRNA2Cholinergic receptor, nicotinic, alpha 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CKMT1ACreatine kinase, mitochondrial 1AEnzymes
FDA approved drug targets
Predicted secreted proteins
Mixed
CKMT1BCreatine kinase, mitochondrial 1BEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
CSF2RAColony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CTLA4Cytotoxic T-lymphocyte-associated protein 4CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CYP17A1Cytochrome P450, family 17, subfamily A, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
DBHDopamine beta-hydroxylase (dopamine beta-monooxygenase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enriched
DDR2Discoidin domain receptor tyrosine kinase 2CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Actin filaments
Mixed
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Nucleus
Cell Junctions
Tissue enhanced
DPP4Dipeptidyl-peptidase 4CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
EDNRBEndothelin receptor type BDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enhanced
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
F10Coagulation factor XCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
F2RCoagulation factor II (thrombin) receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
F5Coagulation factor V (proaccelerin, labile factor)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enriched
F7Coagulation factor VII (serum prothrombin conversion accelerator)Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
F8Coagulation factor VIII, procoagulant componentCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
F9Coagulation factor IXCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FCGR1BFc fragment of IgG, high affinity Ib, receptor (CD64)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
NucleoliExpressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesMixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Endoplasmic reticulumTissue enriched
FGFR4Fibroblast growth factor receptor 4Cancer-related genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced

Page of 4 | next »